CN Patent

CN102670597B — 5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途

Assigned to Institute of Basic Medical Sciences of CAMS and PUMC · Expires 2014-07-09 · 12y expired

What this patent protects

本发明涉及5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途。

USPTO Abstract

本发明涉及5-(4-羟基-3-甲氧基苯亚甲基)罗丹宁在制备治疗帕金森氏病药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN102670597B
Jurisdiction
CN
Classification
—
Expires
2014-07-09
Drug substance claim
No
Drug product claim
No
Assignee
Institute of Basic Medical Sciences of CAMS and PUMC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.